EBS: Strong growth, innovation, and global expansion position the firm as a leader in public health preparedness
The session highlighted a robust portfolio in biodefense and opioid overdose solutions, ongoing transformation for operational efficiency, and strong financial improvements. Growth is driven by international expansion, new product development, and proactive risk management.Based on Emergent BioSolu…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.